RICHMOND, Va.--(BUSINESS WIRE)--Commonwealth Biotechnologies, Inc. (“CBI”) (NASDAQ Capital Market: CBTE) announced today that Mr. Joseph Slay has resigned his seat on the Board of Directors of CBI, effective immediately. In accepting his resignation Dr. Richard J. Freer, Chairman and COO of CBI said, “Mr. Slay has been a very effective member of the board and we thank him for his good work on our behalf.”
